GLP-1, an incretin hormone that can modulate several metabolic pathways, has become a popular target for pharmacological intervention in metabolic disorders [3]
Xu X, Lemaire C, Grzych JM, Pierce RJ, Raccurt M, Mullier F, Zerimech F, Decavel JP, Peyrol S, Liu J, Fontaine J, Lafitte S, Capron A and Cesbron JY
A 2024 randomized controlled trial involving 60 women aged 4065 applied a 0.1% GHK-Cu cream twice daily for twelve weeks and reported a 31% reduction in wrinkles by imaging analysis, along with 28% improved skin elasticity relative to placebo and a 15.6% increase in collagen density measured by ultrasound
Look directly at a camera that is at eye level